Radium 223 therapy is a type of targeted radiotherapy specifically used for treating cancers that have metastasized to the bone, particularly in prostate cancer. Unlike traditional radiotherapy, which uses external beams of radiation, radium 223 is a radioactive isotope that is administered intravenously. It mimics calcium and selectively targets bone metastases, emitting alpha particles that destroy cancer cells while minimizing damage to surrounding healthy tissue.